Jan 22- St. Jude Medical Inc on Wednesday reported a higher fourth-quarter profit, as it had indicated it would, and forecast growth in both earnings and revenue in 2014.. Jude on Jan. 13 said that the fourth quarter had been better than expected and that it would report earnings of 97 cents to 99 cents per share, excluding restructuring costs and charges.
Jan 21- Jan 21- Covidien Plc said it would stop making a device for treating high blood pressure due to weak demand for the product, raising more doubts about the future of the novel technology.
Jan 9- Medtronic Inc's experimental device to treat high blood pressure failed to meet its main goal in a clinical trial, sending the company's shares down nearly 5 percent.
Some of Monday's midday movers:
Nov 19- Medtronic Inc reported higher quarterly earnings on Tuesday as stronger sales of its implantable devices to treat abnormal heart rhythms offset weakness in its spinal products business.
*Seeking U.S. partners, cites J&J, Medtronic, St Jude, Edwards. The French company is also seeking a partner in the United States to enter the world's largest healthcare market, and is in contact with Johnson& Johnson, Medtronic, St Jude Medical and Edwards Lifesciences, Marcello Conviti said.
"Mad Money" host Jim Cramer made calls on stocks viewers asked about.
Take a look at some of Wednesday's midday movers:
*Third-quarter profit of 90 cents/ shr vs est 89 cents. Oct 16- St. Jude Medical raised its full-year earnings forecast and said its implantable devices that treat irregular heartbeats gained market share in the United States.
Oct 16- St. Jude Medical posted a 49 percent jump in third-quarter profit as increased sales of devices to treat abnormal heart rhythms offset a decline in sales of pacemakers. Jude rose to $262 million, or 90 cents per share, in the three months to Sept. 28, from $176 million, or 56 cents per share, a year earlier.
With a deadline hanging over Congress, stocks could be whipped by headlines from Washington but should ultimately be able to limp through the drama.
Talking Squawk looks at our big interviews with Daryl from "The Walking Dead", Jack Welch, Jim Chanos and T. Boone Pickens. Plus, we debate the merits of megayachts versus kayaks.
*Senate rejects House-approved budget bill; gov't shutdown more likely. NEW YORK, Sept 30- U.S. stocks closed lower on Monday with just hours to go before a midnight deadline to avert a federal government shutdown, but major indexes ended September with solid monthly gains.
For investors still uncertain about the euro zone's prospects, analysts say there is a safer way to play its nascent recovery: Buy shares of U.S. companies that do a lot of business there.
Stocks squeezed out modest gains in choppy trading Wednesday, following comments from Fed Chairman Ben Bernanke that monetary policy will remain highly accommodative even as the central bank could start to scale back its bond buying later this year.
Fed Chairman Ben Bernanke is not likely to say much new when he testifies before Congress Wednesday, but even so, he could rock the markets.
Earnings season kicks into high gear in the week ahead. Plus, at least 10 Fed speeches. How risk-averse are investors? Oh, this is going to put them to the test. Rest up.
Some of the names on the move ahead of the open.
Check out which companies are making headlines before the bell Monday:
Stocks recovered from their lows Friday to close narrowly mixed, but the S&P 500 managed to pull off its seventh-straight week higher.